TL;DR. Factor investing says that long-run stock returns are explained not by individual stock picks but by a handful of systematic characteristics — how cheap a stock is, how recently it has risen, how profitable the business is, how small the company is, and how stable the price has been. Decades of academic work and trillions of dollars in “smart beta” ETFs are built on that idea. It is also full of traps: factors go through long droughts, definitions vary by vendor, and many premia have shrunk since they were first published.
The core idea, in one paragraph
The Capital Asset Pricing Model, built in the 1960s, said one thing drives a stock’s expected return: its sensitivity to the overall market, called beta. By the 1980s, researchers had found that beta alone could not explain the cross-section of returns. Small stocks beat big ones. Cheap stocks beat expensive ones. Yesterday’s winners kept winning for a while. These persistent patterns are factors. Factor investing is the discipline of measuring those patterns, building portfolios that tilt toward them, and accepting the long stretches of underperformance that come with the territory.
Where the factors came from
A short timeline, paraphrased from the Factor investing survey:
- 1976. Stephen Ross publishes the Arbitrage Pricing Theory, which allows for multiple sources of systematic risk — the theoretical opening for everything that follows.
- 1977. Sanjoy Basu documents that low price-to-earnings stocks beat high P/E stocks. The value premium is born.
- 1981. Rolf Banz finds the same for small-cap stocks. The size premium is named.
- 1992–1993. Eugene Fama and Kenneth French formalise the three-factor model — market, size (SMB), and value (HML) — in the Journal of Finance and the Journal of Financial Economics.
- 1993. Narasimhan Jegadeesh and Sheridan Titman show that buying past 12-month winners and shorting past 12-month losers earns a positive excess return. Momentum is recognised as a factor.
- 1997. Mark Carhart bolts momentum onto Fama–French to get a four-factor model, published in the Journal of Finance (52(1): 57–82).
- 2014. Andrea Frazzini and Lasse Pedersen publish “Betting Against Beta”, anchoring the low-volatility anomaly in a constraints-based theory.
- 2015. Fama and French expand to a five-factor model by adding profitability (RMW) and investment (CMA), conceding that value alone could not absorb everything.
- 2019. Clifford Asness, Frazzini, and Pedersen publish “Quality Minus Junk”, formalising the quality factor that AQR now publishes as a monthly dataset.
That sequence matters, because every commercial “factor product” you can buy traces back to one of those academic papers.
The five workhorse equity factors
The table below names the factors most managers and ETFs use, the rough characteristic each one ranks on, and the academic anchor.
| Factor | What it ranks on | Trade in one line | Academic anchor |
|---|---|---|---|
| Value (HML) | Book-to-market, P/E, P/CF, EV/EBITDA | Long cheap, short expensive | Basu 1977; Fama–French 1992 |
| Size (SMB) | Market capitalisation | Long small caps, short large caps | Banz 1981; Fama–French 1992 |
| Momentum (MOM / UMD) | Trailing 12-month return, skipping the most recent month | Long past winners, short past losers | Jegadeesh–Titman 1993; Carhart 1997 |
| Quality (QMJ) | Profitability, growth, safety, payout | Long high-quality companies, short “junk” | Asness, Frazzini, Pedersen 2019; Fama–French 5-factor (RMW) 2015 |
| Low Volatility (BAB) | Trailing realised volatility or beta | Long low-beta stocks, short (or underweight) high-beta stocks | Haugen–Heins 1972; Frazzini–Pedersen 2014 |
How a factor portfolio is actually built
The mechanical recipe is identical across factors. It is worth understanding once, because it tells you what is really inside an “HML” or “momentum” number you see in a research report.
- Pick a characteristic. For value: book-to-market ratio. For momentum: the stock’s return over the last 12 months, skipping the most recent month.
- Rank the universe. Sort every stock in the investable universe from high to low on that characteristic.
- Form the long and short legs. Buy the top decile (or top 30%), short the bottom decile (or bottom 30%).
- Rebalance. Monthly for momentum, annually for value, somewhere in between for quality. Higher turnover means higher trading costs.
- Report the spread. The factor return is the long leg minus the short leg, gross of costs. That is the number Ken French publishes for the academic factors.
A simple worked example: building a one-stock momentum signal
Suppose you want to know whether a stock is “in” the momentum factor’s long leg at the end of June 2026. The standard academic definition is the return from t−12 to t−1, skipping the most recent month to avoid short-term reversal.
- Take the stock’s price on May 31, 2025 (the t−13 point) and on May 31, 2026 (the t−1 point).
- Compute the total return, including dividends, between those two dates.
- Do the same for every other stock in your universe.
- Rank all stocks. If yours sits in the top 30%, it goes into momentum’s long leg next month.
- If it sits in the bottom 30%, it goes into the short leg. The middle 40% is excluded from the factor portfolio entirely.
That is it. No earnings call read-through, no analyst forecast, no chart pattern. The momentum factor is a mechanical, rules-based sort. The same is true for value (sort on book-to-market), quality (sort on a composite of profitability, growth, safety, payout), and low-vol (sort on trailing volatility).
Common mistakes — where factor investing goes wrong
1. Treating a long-run premium as a year-by-year guarantee
Every factor has multi-year droughts. The Fama–French value factor (HML) underperformed for most of the 2010s. Momentum had a famous crash in early 2009 when past losers (beaten-down financials) ripped higher off the bottom. Low-vol lagged badly in the 2020–2021 reopening rally when the worst-quality, highest-beta names led. If you cannot stomach five-year underperformance, factor tilts are not for you.
2. Mistaking the academic factor for what your ETF actually does
Ken French’s HML is a long-short, dollar-neutral, equal-weighted portfolio updated monthly. A real-world “value” ETF is typically long-only, market-cap weighted, screened for liquidity, and rebalanced semi-annually. Those are not the same product. iShares MSCI USA Value Factor (VLUE), iShares MSCI USA Momentum Factor (MTUM), iShares MSCI USA Quality Factor (QUAL), iShares MSCI USA Min Vol Factor (USMV), and Vanguard equivalents all make slightly different methodological choices — index, definition of the characteristic, weighting scheme, turnover constraints. Two ETFs branded the same way can produce noticeably different returns.
3. Double-counting via factor overlap
Quality and low-volatility are correlated. Value and small-cap are correlated. Stacking three or four factor ETFs without checking the joint exposure can leave you with an unintended bet (often: a giant overweight to defensives and small banks).
4. Ignoring transaction costs and tax friction
Momentum’s paper Sharpe ratio looks heroic in Ken French’s monthly file. Most of that premium can be eaten by turnover when you trade real stocks at real spreads. The same goes for small-cap value, which is concentrated in stocks with the widest bid–ask spreads. Net-of-cost returns are what you actually keep.
5. Forgetting that some factors may have decayed
The size premium, in particular, has been disputed for decades — the original Banz result was concentrated in micro-caps and in January, and it has been thin since the early 1980s. Even Fama and French wrote in 2015 that adding profitability and investment factors makes the value factor largely “redundant” in their five-factor model. The literature itself has gotten more humble.
Historical context: what factor returns look like over decades
The chart below sketches the qualitative shape of cumulative factor returns since the mid-1960s. The exact line you would draw depends on which dataset and which time window you use, but the broad picture — momentum and quality tending to lead, value through long flats, size barely above zero in real terms — matches what readers can reproduce themselves from the Ken French Data Library and the AQR QMJ dataset.
What about Fama–French 5? And six factors? And one hundred?
In 2015 Fama and French added two more characteristics: RMW (Robust Minus Weak profitability) and CMA (Conservative Minus Aggressive investment). The five-factor model explained the cross-section better than the three-factor version — and, in their own paper, made HML largely redundant once profitability was in. AQR went further with quality, treating profitability, growth, safety, and payout as one composite signal (their QMJ series).
Academic researchers have since published hundreds of candidate factors. John Cochrane famously called this a “factor zoo.” The honest read on the zoo is this: most published factors either fail out-of-sample, overlap heavily with the five workhorses above, or carry economic premia so small they vanish after costs. Sticking to value, momentum, quality, size, and low-vol covers most of what is real.
How investors actually use this
Three common implementations, in order of cost and complexity:
- Single-factor ETFs. Buy a fund that tilts toward one factor — for example, iShares MSCI USA Momentum Factor (MTUM), iShares MSCI USA Quality Factor (QUAL), iShares MSCI USA Min Vol Factor (USMV), or Vanguard Value (VTV). Cheap, transparent, but you accept whatever index methodology the issuer chose.
- Multi-factor ETFs. A fund such as Goldman Sachs ActiveBeta or iShares MSCI Multifactor (LRGF) tilts toward several factors at once, often with a constraint to avoid double-counting. Easier to manage in a portfolio, harder to audit what is driving returns in any given year.
- Quant manager. Firms like AQR, Dimensional Fund Advisors, and Research Affiliates run factor-tilted strategies as separate accounts or mutual funds, usually with proprietary refinements (industry neutralisation, risk targeting, transaction-cost modelling). Higher fees, more methodology control.
None of these is “active stock-picking.” They are rules-based bets on systematic premia.
Related concepts — what to learn next
- CAPM and beta. Read our explainer on beta, alpha, and CAPM to see what factor investing extends and what it replaces.
- P/E and CAPE. The value factor is largely a P/E or book-to-market sort. The P/E ratio explainer and the CAPE explainer show what is actually being ranked.
- DCF. Where value as a factor is empirical, discounted cash flow valuation is the bottom-up reason why cheap stocks might be cheap.
- Sharpe ratio. Factor returns are usually quoted as a Sharpe ratio, not as a raw return. Compare premia like-for-like.
- Sector rotation. Factors and sector rotation overlap: low-vol tilts toward staples and utilities, value tilts toward financials and energy in most regimes.
Sources
- Kenneth R. French — Data Library (Dartmouth Tuck): Fama–French 3-factor, 5-factor, momentum, and reversal series, monthly and daily, US and international.
- AQR Capital Management — Quality Minus Junk Factors, Monthly: US factor data back to 1956, 23 international markets back to 1986.
- Wikipedia: Factor investing: timeline of the literature from Ross (1976) through Fama–French (2015).
- Wikipedia: Fama–French three-factor model: definitions of SMB and HML, with citations to the 1992 Journal of Finance and 1993 Journal of Financial Economics papers.
- Wikipedia: Carhart four-factor model: 1997 paper in Journal of Finance 52(1): 57–82.
- Wikipedia: Low-volatility anomaly: Frazzini and Pedersen, “Betting Against Beta” (2014); earlier evidence in Haugen and Heins (1972).
- MSCI — Factor Investing: the index family behind most large factor ETFs (1,100+ factor indexes).
Disclosure: This article was produced with AI assistance and reviewed before publication. It is for informational purposes only and is not investment advice.